Papers/PMID:37843843
Effect of Resveratrol on Endothelial Function in Patients with CKD and Diabetes: A Randomized Controlled Trial.
Clinical journal of the American Society of Nephrology : CJASN2024The record
1 finding drawn from this paper, on 1 compound across 1 endpoint.
What it reported
How to read these marksWhat moved
1 finding
resveratrol — increases flow-mediated dilation
PreliminaryGrade D, Preliminary. Non-human or in vitro only.Findingreplicated ×1“Compared with placebo, resveratrol supplementation increased flow-mediated dilation (ratio of geometric mean changes and 95% confidence interval for between-group comparisons, 1.43 (1.15 to 1.77); P value = 0.001).”
Quoted verbatim from Effect of Resveratrol on Endothelial Function in Patients with CKD and Diabetes: A Randomized Controlled Trial.. - Study
- crossover
- Participants
- 28
- Duration
- 6 weeks
- Dose
- 400 mg/d
- Population
- adults aged 68 +/- 7 years (84% men) with stage 3 CKD and diabetes; abstract only; primary endpoint
Effect of Resveratrol on Endothelial Function in Patients with CKD and Diabetes: A Randomized Controlled Trial.2024PMID:37843843